Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y | YTD ▼ | 3y | 5y |
---|---|---|---|---|---|---|---|
Advicenne | -0.890% | 5.674% | 9.693% | -48.694% | -30.832% | -83.164% | - |
Aspira Womens Health Inc. | -1.500% | -6.429% | -10.274% | -35.309% | -35.309% | -95.633% | -85.185% |
Harvard Bioscience | -3.750% | -13.483% | -22.222% | -41.887% | -35.565% | -45.965% | 47.580% |
Orasure Tech | 5.800% | -6.139% | -11.402% | -28.722% | -36.376% | -37.500% | -36.976% |
Rigel Pharmaceutical Inc. | -3.140% | -20.972% | -23.452% | -23.486% | -36.789% | -71.223% | - |
Seres Therapeutics Inc | -12.030% | -18.743% | 35.252% | -82.549% | -36.855% | -95.542% | - |
Coherus Bioscien. | -2.120% | -8.142% | -8.710% | -57.519% | -36.908% | -83.322% | -87.672% |
Strata Skin Sciences Inc. | 2.680% | -9.467% | -36.777% | -66.739% | -37.295% | -74.918% | -85.415% |
DBV Technologies S.A. | -2.180% | -6.260% | -14.869% | -68.432% | -38.364% | -88.313% | -92.654% |
Enlivex Therapeutics Ltd. | -2.920% | -9.524% | -23.121% | -46.800% | -40.625% | -81.655% | - |
Aurinia Pharmaceuticals Inc. | 2.170% | 1.458% | 3.291% | -51.544% | -41.080% | -47.219% | -12.532% |
Trevena Inc. | 0.420% | -0.140% | 0.421% | -74.859% | -41.489% | -98.803% | -98.798% |
AB Science S.A. | -3.450% | 3.695% | -6.652% | -56.191% | -42.329% | -85.176% | -52.803% |
Accuray Inc. | 1.360% | -9.146% | -30.374% | -54.294% | -43.561% | -58.840% | - |
Editas Medicine Inc | 2.530% | -0.795% | -10.236% | -40.746% | -44.331% | -80.847% | -73.858% |
Prothena Corp. plc | -1.510% | -12.727% | -8.571% | -71.556% | -44.828% | 1.053% | - |
Terumo Corp. | 2.530% | 0.625% | 1.258% | -43.706% | -45.238% | -45.973% | - |
EyePoint Pharmaceuticals Inc. | -1.920% | 2.720% | -46.907% | 107.890% | -47.056% | 52.081% | - |
MicroVision Inc | 10.980% | -14.120% | -14.541% | -44.590% | -48.945% | -88.827% | 65.308% |
Carisma Therapeutics Inc. | -1.610% | -9.733% | -25.193% | -88.482% | -50.584% | -96.481% | -97.657% |
MacroGenics Inc. | 1.230% | -72.485% | -75.103% | -37.758% | -54.356% | -82.840% | - |